These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 18219852)
1. [Establishment of a CXCR4-expressing gastric cancer cell line in nude mice and the effect of AMD 3100 on tumor regression]. Iwanaga T; Iwasaki Y; Ohashi M; Nunobe S; Iwagami S Gan To Kagaku Ryoho; 2007 Nov; 34(12):1917-9. PubMed ID: 18219852 [TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of CXCR4 blockers on a CXCR4-expressing gastric cancer cell line in nude mice]. Iwanaga T; Iwasaki Y; Ohashi M; Ohinata R; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D Gan To Kagaku Ryoho; 2012 Nov; 39(12):1788-90. PubMed ID: 23267887 [TBL] [Abstract][Full Text] [Related]
3. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691 [TBL] [Abstract][Full Text] [Related]
4. CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer. Xue J; Li R; Gao D; Chen F; Xie H Int J Nanomedicine; 2020; 15():5701-5718. PubMed ID: 32848392 [TBL] [Abstract][Full Text] [Related]
5. [Effect of chemokine stromal cell derived factor-1 and its receptor CXCR4 on the peritoneal carcinometastasis of gastric cancer]. Ding YL; Zhang JL; Tang SF; Fu QY; Li ZT Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):202-5. PubMed ID: 18361822 [TBL] [Abstract][Full Text] [Related]
6. CXCR4-Targeted and Redox Responsive Dextrin Nanogel for Metastatic Breast Cancer Therapy. Zhang F; Gong S; Wu J; Li H; Oupicky D; Sun M Biomacromolecules; 2017 Jun; 18(6):1793-1802. PubMed ID: 28445650 [TBL] [Abstract][Full Text] [Related]
7. Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Yasumoto K; Koizumi K; Kawashima A; Saitoh Y; Arita Y; Shinohara K; Minami T; Nakayama T; Sakurai H; Takahashi Y; Yoshie O; Saiki I Cancer Res; 2006 Feb; 66(4):2181-7. PubMed ID: 16489019 [TBL] [Abstract][Full Text] [Related]
8. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer. Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564 [TBL] [Abstract][Full Text] [Related]
9. A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis. Xiang Z; Zhou ZJ; Xia GK; Zhang XH; Wei ZW; Zhu JT; Yu J; Chen W; He Y; Schwarz RE; Brekken RA; Awasthi N; Zhang CH Oncogene; 2017 Sep; 36(36):5122-5133. PubMed ID: 28481874 [TBL] [Abstract][Full Text] [Related]
10. [Effect of stromal cell-derived factor-1 and its receptor CXCR4 on liver metastasis of human colon cancer]. Ding YL; Fu QY; Tang SF; Zhang JL; Li ZY; Li ZT Zhonghua Wai Ke Za Zhi; 2009 Feb; 47(3):210-3. PubMed ID: 19563077 [TBL] [Abstract][Full Text] [Related]
11. Adenosine A2A receptor activation reduces brain metastasis via SDF-1/CXCR4 axis and protecting blood-brain barrier. Chen L; Li L; Zhou C; Chen X; Cao Y Mol Carcinog; 2020 Apr; 59(4):390-398. PubMed ID: 32037613 [TBL] [Abstract][Full Text] [Related]
12. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice]. Zhang MX; Han N; Yu SY; Leng Y Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828 [TBL] [Abstract][Full Text] [Related]
13. LRP6 Ectodomain Prevents SDF-1/CXCR4-Induced Breast Cancer Metastasis to Lung. Zhang J; Chen J; Wo D; Yan H; Liu P; Ma E; Li L; Zheng L; Chen D; Yu Z; Liang C; Peng J; Ren DN; Zhu W Clin Cancer Res; 2019 Aug; 25(15):4832-4845. PubMed ID: 31010839 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of Dipeptidyl Peptidase-4 Accelerates Epithelial-Mesenchymal Transition and Breast Cancer Metastasis via the CXCL12/CXCR4/mTOR Axis. Yang F; Takagaki Y; Yoshitomi Y; Ikeda T; Li J; Kitada M; Kumagai A; Kawakita E; Shi S; Kanasaki K; Koya D Cancer Res; 2019 Feb; 79(4):735-746. PubMed ID: 30584072 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological targeting of CXCL12/CXCR4 signaling in prostate cancer bone metastasis. Conley-LaComb MK; Semaan L; Singareddy R; Li Y; Heath EI; Kim S; Cher ML; Chinni SR Mol Cancer; 2016 Nov; 15(1):68. PubMed ID: 27809841 [TBL] [Abstract][Full Text] [Related]
16. Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma. Li J; Li T; Li S; Xie L; Yang YL; Lin Q; Kadoch O; Li H; Hou S; Xu Z J Investig Med; 2019 Feb; 67(2):338-345. PubMed ID: 30367010 [TBL] [Abstract][Full Text] [Related]
17. Suppression of the SDF‑1/CXCR4/β‑catenin axis contributes to bladder cancer cell growth inhibition in vitro and in vivo. Zhang T; Yang F; Li W; Liu B; Li W; Chen Z; Wang C Oncol Rep; 2018 Sep; 40(3):1666-1674. PubMed ID: 30015971 [TBL] [Abstract][Full Text] [Related]
18. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3. Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312 [TBL] [Abstract][Full Text] [Related]
19. CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer. Guo Q; Gao BL; Zhang XJ; Liu GC; Xu F; Fan QY; Zhang SJ; Yang B; Wu XH Oncol Res; 2014; 22(5-6):247-58. PubMed ID: 26629936 [TBL] [Abstract][Full Text] [Related]
20. [Relationship between chemokine axis CXCL12-CXCR4 and epithelial ovarian cancer]. Guo Q; Wu XH; Lü YP; Yang B; Xu F; Zhang SJ Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(21):1677-80. PubMed ID: 24125682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]